S. A. Danner - Concepedia

Author

S. A. Danner

University of Amsterdam

Also Known As

Angelo D', Mark Gill, S A Danner, S Danner, S. A Danner, S. A. DANNER, S. A. Danner, S. Danner, S.A Danner, S.A. Danner

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam General Department of Preventive Medicine Amsterdam UMC Location University of Amsterdam Dutch Blood Transfusion Society Utrecht University

About

S. A. Danner is an author at University of Amsterdam specializing in medicine, hiv, and aids pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	2.4K
2	Public Health	3	3	66
3	Health Sciences	2	2	93
4	Allergy	2	2	264
5	Social Sciences	1	1	439

S. A. Danner

Publications

Citations

H-Index

Page 1

	Year	Citations
Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 <sup>+</sup> T Cells Z.-Q. Zhang, Troy Schuler, Mary Zupancic, Science ImmunologyViral DynamicCd4 T Cell ResponsesT CellsImmunotherapy	1999	870
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC) Rob Schuurman, Monique Nijhuis, Remko van Leeuwen, The Journal of Infectious Diseases	1995	517
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. Frank Miedema, A Petit, Fokke G. Terpstra, Journal of Clinical Investigation Persistent Hiv InfectionImmunological AbnormalitiesImmunologyCd3 Monoclonal AntibodyHuman Immunodeficiency Virus	1988	439
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. J. M. A. Lange, Deborah A. Paul, Han G. Huisman, BMJ ImmunologyActive Hiv InfectionSerum SamplesHiv Core AntibodiesViral Persistence	1986	342
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Peter Portegies, Jan de Gans, Joep M. A. Lange, BMJ	1989	238
The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects Karl‐Heinz Wiederhold, Alain C. Tissot, Pascal Frey, Journal of Neuroscience	2011	190
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection Marc van der Valk, Elizabeth H. Gisolf, Peter Reiss, AIDS	2001	176
Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Joep M. A. Lange, R A Coutinho, W Krone, BMJ ImmunologyPathologyViral PersistenceHuman RetrovirusPrimary Immunodeficiency	1986	170
Epidemiology of AIDS Dementia Complex in Europe Antonio Chiesi, Stefano Vella, Len Dally, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology Sexual HealthAlzheimer's DiseaseEpidemiological OutcomeGeriatricsTreatment And Prevention	1996	120
Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis M. Koot, Remko van Leeuwen, R. E. Y. de Goede, The Journal of Infectious Diseases	1999	105

Page 1